Globeflex Capital L P United Therapeutics Corp Transaction History

Globeflex Capital L P

$1.03 Billion
Q3 2024

A detailed history of Globeflex Capital L P transactions in United Therapeutics Corp stock. As of the latest transaction made, Globeflex Capital L P holds 60,044 shares of UTHR stock, worth $23.2 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares

60,044

Previous 60,924 1.44%

Holding current value

$23.2 Million

Previous $19.4 Million 10.87%

% of portfolio

2.1%

Previous 2.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $273,715 - $319,924	-880 Reduced 1.44%	60,044 $21.5 Million
Q2 2024 Aug 13, 2024	BUY	$228.26 - $319.04 $455,835 - $637,122	1,997 Added 3.39%	60,924 $19.4 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $193,392 - $231,246	900 Added 1.55%	58,927 $13 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $609,194 - $713,938	2,876 Added 5.21%	58,027 $13.1 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $80,639 - $91,565	-393 Reduced 0.71%	55,151 $12.2 Million
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $820,224 - $1.06 Million	3,851 Added 7.45%	55,544 $12.4 Million
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $3.78 Million - $5.15 Million	18,375 Added 55.15%	51,693 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $5.36 Million - $6.44 Million	26,387 Added 380.71%	33,318 $6.98 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $173,236 - $238,969	-991 Reduced 12.51%	6,931 $1.63 Million
Q4 2021 Feb 10, 2022	SELL	$184.32 - $216.08 $12,349 - $14,477	-67 Reduced 0.84%	7,922 $1.71 Million
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $35,406 - $40,215	-230 Reduced 2.8%	7,989 $1.34 Million
Q4 2020 Feb 11, 2021	SELL	$101.87 - $151.79 $8,251 - $12,294	-81 Reduced 0.98%	8,219 $1.25 Million
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $410,688 - $497,965	-4,111 Reduced 33.12%	8,300 $838,000
Q2 2020 Aug 12, 2020	BUY	$92.74 - $125.82 $1.15 Million - $1.56 Million	12,388 Added 53860.87%	12,411 $1.5 Million
Q1 2020 May 13, 2020	BUY	$79.39 - $115.35 $1,825 - $2,653	23 New	23 $2,000
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $102,452 - $162,731	-1,347 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$107.15 - $126.84 $16,393 - $19,406	-153 Reduced 10.2%	1,347 $158,000
Q3 2018 Nov 09, 2018	BUY	$113.81 - $129.46 $170,715 - $194,190	1,500 New	1,500 $192,000

Others Institutions Holding UTHR

# of Institutions

657

Shares Held

42.8M

Call Options Held

153K

Put Options Held

278K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P United Therapeutics Corp Transaction History